Related Experiment Video

Updated: Aug 23, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Trials of primary prevention by diet or hypolipidemic treatment]

J L Richard1

  • 1INSERM, Unité de recherche d'épidémiologie cardiovasculaire (Unité 258), hôpital Broussais, Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|September 1, 1992
PubMed

Insights

Primary prevention trials confirm that lowering serum cholesterol reduces coronary artery disease risk. Interventions like lipid-lowering drugs and low-saturated fat diets significantly decreased severe coronary events and heart attacks.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Lipid Metabolism

Background:

  • A causal link between elevated serum cholesterol and coronary artery disease (CAD) is established.
  • Primary prevention trials are crucial for confirming such relationships.

Purpose of the Study:

  • To evaluate the effectiveness of interventions aimed at reducing serum cholesterol in preventing ischemic heart disease.
  • To assess the impact of lipid-lowering therapies and dietary modifications on cardiovascular event rates.

Main Methods:

  • Analysis of four major primary prevention trials meeting rigorous methodological standards.
  • Inclusion of trials using lipid-lowering drugs (clofibrate, cholestyramine, gemfibrozil) and a low-saturated fat diet.
  • Focus on middle-aged hypercholesterolemic men with high statistical power to detect risk reduction.

Main Results:

  • Treatment groups showed an 8-13% reduction in serum cholesterol compared to controls.
  • A significant reduction in severe coronary events, myocardial infarction, and sudden death (19-47%) was observed across the four trials.
  • Risk reduction was proportional to serum cholesterol reduction, with specific impacts noted for LDL and HDL cholesterol levels.

Conclusions:

  • Primary prevention trials provide strong evidence for a causal relationship between reduced serum cholesterol and decreased risk of ischemic heart disease.
  • Lipid-lowering interventions and dietary changes are effective in reducing the incidence of major coronary events.
  • Further research is needed to fully understand the impact of these interventions on overall mortality.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...